Clinical outcome and tolerability of sertraline in major depression: a study with plasma levels (Q43986093)

28 November 2017

Clinical outcome and tolerability of sertraline in major depression: a study with plasma levels (English)

1 reference

28 November 2017

1 reference

Massimo C Mauri

1

1 reference

28 November 2017

Valerio Laini

2

1 reference

28 November 2017

Giancarlo Cerveri

3

1 reference

28 November 2017

Marta E Scalvini

4

1 reference

28 November 2017

Lucia S Volonteri

5

1 reference

28 November 2017

Francesca Regispani

6

1 reference

28 November 2017

Lara Malvini

7

1 reference

28 November 2017

Sergio Manfré

8

1 reference

28 November 2017

Luigi Boscati

9

1 reference

28 November 2017

Gabriele Panza

10

1 reference

28 November 2017

1 April 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

28 November 2017

1 reference

28 November 2017

26

1 reference

28 November 2017

3

1 reference

28 November 2017

597-601

1 reference

Effect of sertraline on regional metabolic rate in patients with affective disorder.

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Sertraline. A pharmacoeconomic evaluation of its use in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Sertraline in the prevention of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Nonlinear pharmacokinetics of fluvoxamine and gender differences.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Serum concentrations of fluvoxamine and clinical effects. A prospective open clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Maintenance Phase Efficacy of Sertraline for Chronic Depression A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

The SSRIs: advantages, disadvantages and differences

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Long term efficacy of paroxetine in major depression: A study with plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Sertraline 50 mg daily: the optimal dose in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Analysis of tricyclic antidepressant drugs by gas chromatography using nitrogen-selective detection with packed and capillary columns

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Effect of sertraline on plasma nortriptyline levels in depressed elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

An open study of sertraline in acute and continuation treatment of depressed out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

Clinical Implications of the Pharmacology of Sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900314-1

7 January 2021

10.1016/S0278-5846(01)00314-1

Identifiers

DOI

1 reference

28 November 2017

1 reference